GGrantIndex
Sort

64,565 grants matching drug discovery

Molecular Mechanism of an Exporter-like ABC Importer YbtPQ

$499,200
Hongjin Zheng · University Of Colorado Denver · R01 · FY2024 · AI

Development of Rodent Self-Administration Vapor Inhalation Chambers for THC

$499,190
Maury D. Cole · La Jolla Alcohol Research, Inc. · R44 · FY2016 · DA

Mycobacterial Sulfation Pathways

$499,188
Carolyn R Bertozzi · University Of California Berkeley · R01 · FY2010 · AI

Southeast Regional Centers of Excellence for Biodefense & Emerging Infectious Di

$499,170
Philip Frederick Sparling · Univ Of North Carolina Chapel Hill · U54 · FY2010 · AI

Molecular Drivers of Vascular Stiffness and Metabolic Dysfunction in HIV-Induced Pulmonary Arterial Hypertension

$499,098
Stephen Y Chan · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · HL

Data Coordination and Integration Center for LINCS-BD2K

$499,096
Avi Ma'ayan · Icahn School Of Medicine At Mount Sinai · U54 · FY2016 · HL

Targeted siRNA delivery to aberrantly activated leukocytes for treating colitis

$499,096
Timothy A Springer · Immune Disease Institute, Inc. · RC1 · FY2010 · DK

mRNA Capping Enzymes

$499,057
Stewart H Shuman · Sloan-Kettering Inst Can Research · R01 · FY2009 · GM

A scalable image-based approach for profiling and annotating very large compound

$499,024
Lani F Wu · University Of California, San Francisco · R01 · FY2018 · CA

A scalable image-based approach for profiling and annotating very large compound

$499,024
Lani F Wu · University Of California, San Francisco · R01 · FY2016 · CA

Structure and dynamics of G protein coupled receptor-G protein complexes

$499,022
Roger K Sunahara · University Of California, San Diego · R01 · FY2016 · GM

Neuroimaging-based biomarkers for two components of pain

$499,015
Edward E. Smith · Columbia Univ New York Morningside · RC1 · FY2010 · DA

Identifying the origins of resilience through human single cell molecular networks, then testing them in diverse, resilient, human IPS lines

$499,005
Christopher A. Gaiteri · Rush University Medical Center · R01 · FY2022 · AG

Hamamatsu FDSS7000 Functional HTS Drug Screening System

$499,000
Munirathnam K Chaguturu · University Of Kansas Lawrence · S10 · FY2010 · RR

NEW DRUG TARGETS FOR APOPTOSIS

$498,959
Robert T Dorr · University Of Arizona · P01 · FY2006 · CA

High-activity mutants of cocaine esterase for treatment of drug addiction

$498,945
Chang-Guo Zhan · University Of Kentucky · R01 · FY2008 · DA

T. vaginalis viruses as mucosal immunity modifiers with impact on women's health

$498,935
Raina N Fichorova · Brigham And Women'S Hospital · RC1 · FY2010 · AI

Bladder drug delivery using intravesical liposomes to treat overactive bladder

$498,910
Jonathan H Kaufman · Lipella Pharmaceuticals, Inc. · R44 · FY2012 · DK

Targeting hybrid histidine kinase for broad spectrum antifungal therapy

$498,908
Bruce Steven Klein · University Of Wisconsin-Madison · RC1 · FY2009 · AI

Molecular Mechanisms of Chemoprevention: Dithiolethiones

$498,850
Thomas W Kensler · Johns Hopkins University · R01 · FY2007 · CA

SBIR Phase II: Tissue Engineered Cartilage for Drug Discovery

$498,843
Brian E Pfister · Articular Engineering, Llc · · FY2004 · TIP

Data Analysis Unit

$498,776
Gad A Getz · Dana-Farber Cancer Inst · U2C · FY2021 · CA

HER2-targeted exosomal delivery of therapeutic mRNA for enzyme pro-drug therapy

$498,770
Ac Matin · Stanford University · UH2 · FY2013 · TR

Targeting chemosensory signaling in Aedes aegypti mosquitoes

$498,760
David Nigel Jones · University Of Colorado Denver · R01 · FY2016 · AI

Optimization of non-peptide probes for the NPFF receptor system

$498,705
Christopher R McCurdy · University Of Mississippi · R01 · FY2014 · DA